NetScientific plc (NSCI) ORD GBP0.05
Share news, reports & tips
7 June 2021 09:38
(Sharecast News) - Life sciences investment company NetScientific announced on Monday that its subsidiary ProAxsis has entered into an exclusive licensing agreement with AstraZeneca.
10 December 2020 15:35
(Sharecast News) - Technology commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has been awarded a high impact Innovate UK grant, as part of the recent...
19 November 2020 16:28
(Sharecast News) - Life sciences, technology investment and commercialisation company NetScientific announced on Thursday that its portfolio company ProAxsis has appointed DiaPharma Group as the exclusive...
27 October 2020 15:55
(Sharecast News) - Life sciences and technology investor NetScientific announced on Tuesday that its portfolio company PDS Biotechnology has opened the phase 2 clinical trial of 'PDS0101' in...
16 October 2020 09:54
(Sharecast News) - Life sciences and technology commercialisation and investment company NetScientific has agreed to acquire the outstanding minority interest of 43.6% of its portfolio company ProAxsis, it...
12 August 2020 11:02
(Sharecast News) - Healthcare intellectual property company NetScientific announced on Wednesday that its portfolio company PDS Biotechnology has finalised the pricing of its underwritten public offering,...
5 August 2020 09:22
(Sharecast News) - Healthcare intellectual property commercialisation company NetScientific has conditionally agreed to acquire EMV Capital, an investment services company with interests in the industrial...
18 June 2020 10:21
(Sharecast News) - NetScientific said one of its portfolio companies had signed a deal to speed up development of a potential Covid-19 vaccine.
25 April 2019 08:48
(Sharecast News) - NetScientific chief executive François Martelet will depart the group on 30 April in order to assist the company in reducing its central costs and to pursue other career opportunities.
14 March 2019 14:33
(Sharecast News) - NetScientific was forced to respond to the recent skyrocketing of its share price on Thursday, with the board claiming it was not aware of any reason for such movement.
20 December 2018 15:02
(Sharecast News) - Healthcare intellectual property commercialisation group NetScientific updated the market on its strategic review on Thursday, which it announced in late November.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.